GAM Multistock - Swiss Equity CHF RaRegister to Unlock Ratings |
Performance History | 29/02/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 14.7 | 27.8 | -16.1 | 19.4 | -1.3 | |
+/-Cat | 4.3 | 7.8 | -7.3 | 8.5 | 0.2 | |
+/-B’mrk | - | 5.5 | -8.9 | 10.8 | 0.2 | |
Category: Switzerland Equity | ||||||
Category Benchmark: Morningstar Switzerland TME... |
Key Stats | ||
NAV 27/03/2024 | CHF 146.58 | |
Day Change | -0.24% | |
Morningstar Category™ | Switzerland Equity | |
ISIN | LU1778939519 | |
Fund Size (Mil) 26/03/2024 | CHF 212.59 | |
Share Class Size (Mil) 26/03/2024 | CHF 0.15 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 19/02/2024 | 0.75% |
Investment Objective: GAM Multistock - Swiss Equity CHF Ra |
The investment objective of the Company is to achieve long-term capital growth by investing at least two thirds of the fund’s assets in a portfolio of carefully selected shares, other equity securities and warrants on shares and equity securities (up to a maximum of 15% of the assets of the Subfund) of companies with their registered office or major part of their business activities in Switzerland. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Daniel Häuselmann 01/05/2006 | ||
Inception Date 26/02/2018 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
SIX SPI TR CHF | Morningstar Switzerland TME NR CHF |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for GAM Multistock - Swiss Equity CHF Ra | 29/02/2024 |
|
|
Top 5 Holdings | Sector | % |
Novartis AG Registered Shares | Healthcare | 8.41 |
Nestle SA | Consumer Defensive | 5.89 |
Roche Holding AG | Healthcare | 5.30 |
Holcim Ltd | Basic Materials | 4.95 |
UBS Group AG | Financial Services | 4.69 |
Increase Decrease New since last portfolio | ||
GAM Multistock - Swiss Equity CHF Ra |